Understanding the Market | ARTINI HLDG surged over 48% during the session after reaching a strategic cooperation with GYBYS to jointly develop products in the health and wellness sector and expand the market
ARTINI HLDG has reached a strategic cooperation with BAIYUNSHAN PH, with the stock price rising over 48% during the session, and as of the time of publication, it has increased by 38.33%, trading at HKD 0.142, with a transaction volume of HKD 2.2969 million. The two parties will jointly develop products in the health and wellness sector, including natural plant extracts and functional health products, and plan to launch these products in overseas markets. This cooperation aligns with ARTINI HLDG's business development strategy and is expected to enhance its core competitiveness and open up new revenue sources
According to Zhitong Finance APP, ARTINI HLDG (00789) surged over 48% during the trading session, and as of the time of writing, it has risen by 38.33%, trading at HKD 0.142, with a transaction volume of HKD 2.2969 million.
In terms of news, ARTINI HLDG announced that the company has signed a strategic cooperation agreement with GYBYS, aiming to jointly develop products in the health and wellness sector and expand the market. The two parties will collaborate on innovative products in the health and wellness field, including natural plant extracts, functional health products, and personal care products. Additionally, they plan to promote the collaboratively developed products and related existing products to overseas markets. It is reported that GYBYS is one of the subsidiaries of Guangzhou Baiyunshan Pharmaceutical Group, focusing on the health and wellness industry.
The announcement stated that the group has been actively expanding its sales business in beauty and health products in recent years. The strategic cooperation intention with GYBYS aligns with the group's business development strategy and long-term layout in the health and wellness industry. The board believes that this strategic cooperation can leverage the group's advantages in international markets and sales platforms, along with GYBYS's technological, brand, and product advantages, to achieve synergies. This move is expected to enrich the group's product portfolio and enhance its core competitiveness in the health and wellness sector, opening up new revenue sources. Therefore, the board believes that signing the cooperation agreement with GYBYS is in the overall interest of the company and its shareholders
